Complement Protein C1q Enhances Macrophage Foam Cell Survival and Efferocytosis.
Marc C PulancoJason CosmanMinh-Minh HoJessica HuynhKarina FingJacqueline TurcuDeborah A FraserPublished in: Journal of immunology (Baltimore, Md. : 1950) (2016)
In the atherosclerotic lesion, macrophages ingest high levels of damaged modified low-density lipoproteins (LDLs), generating macrophage foam cells. Foam cells undergo apoptosis and, if not efficiently cleared by efferocytosis, can undergo secondary necrosis, leading to plaque instability and rupture. As a component of the innate immune complement cascade, C1q recognizes and opsonizes modified forms of LDL, such as oxidized or acetylated LDL, and promotes ingestion by macrophages in vitro. C1q was shown to be protective in an atherosclerosis model in vivo. Therefore, this study aimed to investigate whether ingestion of modified LDL in the presence of C1q alters macrophage foam cell survival or function. In an unbiased transcriptome analysis, C1q was shown to modulate expression of clusters of genes involved in cell death and apoptosis pathways in human monocyte-derived macrophages ingesting modified LDL; this was validated by quantitative PCR in human and murine macrophages. C1q downregulated levels and activity of active caspase-3 and PARP-1 in human and mouse macrophages during ingestion of modified LDL. This led to a measurable increase in survival and decrease in cell death, as measured by alamarBlue and propidium iodide assays, respectively. C1q opsonization also increased phagocytosis and efferocytosis in macrophage foam cells. These data suggest that C1q promotes macrophage survival during ingestion of excess cholesterol, as well as improves foam cell efferocytic function. This may be important in slowing disease progression and provides insight into the protective role of C1q in early atherosclerosis.
Keyphrases
- cell cycle arrest
- cell death
- induced apoptosis
- endothelial cells
- low density lipoprotein
- endoplasmic reticulum stress
- adipose tissue
- pi k akt
- oxidative stress
- cardiovascular disease
- induced pluripotent stem cells
- innate immune
- dendritic cells
- dna damage
- type diabetes
- pluripotent stem cells
- poor prognosis
- cell therapy
- high throughput
- artificial intelligence
- single cell
- machine learning
- binding protein
- immune response
- peripheral blood
- big data